This week marks two years since the WHO declared a pandemic. As the Omicron wave recedes, here are some longer-form perspectives on where we are headed and where we should perhaps be headed instead. Plus a Ukrainian frippery. Quote of … Continue reading →
Items of recent pandemic news: A new, wildly divergent SARS-CoV-2 strain in deer; mental health sequelae in Covid-19 survivors; an update on locating a supply of Paxlovid; new CDC masking guidance; and more. Plus a Ukrainian frippery. Quote of the … Continue reading →
Items of recent pandemic news: Antihistamines may help some long Covid; J&J pauses manufacturing vaccine; FDA authorizes Eli Lilly’s injectable monoclonal; how boosters wane; and a further delay in shots for the youngest children. Plus a frippery. Quote of the … Continue reading →
Items of recent pandemic news: Historical perspective and promising research on long Covid; beginning Omicron-targeted vaccine trials; press attention for a new CBD study; Hong Kong’s zero-Covid strategy and Omicron; and BA.2 in the US. Plus a frippery. Quotes of … Continue reading →
Items of recent pandemic news: The Great Resignation among healthcare workers; the CDC may stop talking about herd immunity; the sobering prevalance of long Covid; the fifth pandemic wave crashing over Europe; and considerations for oral antivirals. Plus a frippery. … Continue reading →
Items of recent pandemic news: Detection in Laotian bats of possible SARS-CoV-2 precursors; Covid-19’s effects on the brain; progress towards an antiviral pill; why the US may fail the next pandemic too; and more. Plus a frippery. Lessons not learned … Continue reading →
Items of recent pandemic news: Auto-antibodies in long Covid; Moderna’s durability benefit over Pfizer; results from Johnson & Johnson’s two-dose trial; Pfizer’s effectiveness in kids 5-11; and who gets a Pfizer booster. Plus a frippery. FDA, CDC committee approve boosters … Continue reading →
Items of recent pandemic news: Vaccination halves chances of long Covid; the role of auto-antibodies in severe disease; rising out-of-pocket costs of Covid; the unlikelihood that September 20 will see booster shots; and more. Plus a frippery. 1. Boosters will … Continue reading →
Items of recent pandemic news: China will donate 2 billion doses; the unvaxxed consider shots more dangerous than Covid-19; FDA is fast-tracking full approval for Pfizer; countries and the WHO weigh booster shots; and more. Plus a frippery. 1. Pfizer … Continue reading →
This week the Update moves from its former strictly biweekly cadence to a weekly format; each issue will encompass a larger number of brief items. There may occasionally be longer features. Fear not, the frippery is here to stay. mRNA … Continue reading →
Three items of pandemic news: Long Covid in children; an FDA panel confirms an excess of heart inflammation following mRNA vaccination; and how the American tendency to individualism over collectivism hamstrung our pandemic response. Plus news briefs and a frippery. … Continue reading →
Herewith two items of recent pandemic news: Some clarity on long Covid and its relation to two known autonomic conditions; and watching for cases of heart inflammation in young men after mRNA vaccination. Plus news briefs and a frippery. Teens, … Continue reading →
Herewith three items of recent pandemic news: The toll of long Covid; Johnson & Johnson has no vaccine to ship; and the CDC’s unexpected new guidance on mask use in the vaccinated. Plus news briefs and a frippery. The CDC … Continue reading →
Belatedly, three items of recent pandemic news: Novavax and the EU; a detailed study of long haulers in the VA health care system; and the imminent authorization of Pfizer’s vaccine for young adolescents. Plus news briefs and a frippery. Authorization … Continue reading →
Herewith three items of pandemic news you may have missed recently: Disparate theories of long Covid; Europe locks in 1.8 billion Pfizer doses; and the troubles attendant upon Russia’s Sputnik V vaccine. Plus news briefs and a frippery. Russia’s Sputnik … Continue reading →
